Kategorie: AktualnościBadania
Aktualności
SOM Biotech kończy proces rekrutacji w badaniu fazy IIb leczenia pląsawicy w chorobie Huntingtona
SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligence platform (SOMAIPRO®), is pleased to announce that the recruitment of the Phase IIb clinical study with SOM3355 as a Czytaj dalej...
0 komentarzy